Trading Strategy partnership with Enzyme enhances on-chain asset management 

Chain links.

Trading Strategy partnership with Enzyme enhances on-chain asset management  Duncan is an award-winning technology industry analyst, specialising in cloud computing, blockchain, martech and edge computing.

Trading Strategy has partnered with Enzyme to bring sophisticated algorithmic trading to DeFi and to evolve on-chain asset management.

Enzyme users can now access sophisticated algorithmic trading strategies created by Trading Strategy’s expert quant and strategy creator community through the Enzyme app. Strategies will be available both on Enzyme’s website and Trading Strategy’s website, which is accessible through a different frontend. For Enzyme users, these features will appear as a vault with a special Asset Manager that is executed by an automated protocol.

For users looking to create their own algorithmic trading strategies for DeFi, it is now possible to create and backtest these Python based strategies by using the Trading Strategy framework and protocol, whilst having the familiarity and trust of using Enzyme’s smart vaults.

The strategic partnership will provide DeFi users with access to professional and sophisticated financial tools. The two teams will collaborate from both a technical and operational perspective, making DeFi more professional and accessible. 

Trading Strategy will utilise Enzyme’s smart on-chain vaults, which provide secure, transparent and trusted smart contracts. Enzyme users can interact with decentralised exchanges, protocols and execute trades on-chain. Enzyme’s on-chain vaults have a proven track record in the DeFi space with over 1,300 live vaults and highs of $230M+ in assets under management. Trading Strategy users will benefit from enhanced security, better trade execution and more transparency through Enzyme’s smart vaults without needing the technical blockchain knowhow or resources to safely execute trades automatically. This leaves more time to focus on developing better performing trading strategies.

Mona El Isa, founder at Enzyme, said: “This partnership opens up a crucial piece of infrastructure for professional quants interested in digital assets. The combination of Enzyme’s asset management system and Trading Strategy’s quant framework creates new possibilities to build and backtest on-chain DeFi strategies in a transparent, non-custodial and secure way. Making this accessible directly via the Enzyme app provides a simple and seamless user experience.” 

Mikko Ohtamaa, CEO & co-founder at Trading Strategy, said: “Enzyme is one of the most mature DeFi protocols in the market, showing a real use case for public blockchains. By having robust Python-based trading automation support from Trading Strategy, Enzyme users can benefit from advanced systematic trading strategies and AI, besides discretionary management by asset managers.” 

Want to learn more about blockchain from industry leaders? Check out Blockchain Expo taking place in Amsterdam, California and London.

Explore other upcoming enterprise technology events and webinars powered by TechForge here.

Tags: , ,

View Comments
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *